Cargando…
“BAX602” in Preventing Surgical Adhesion after Extracorporeal Ventricular Assist Device Implantation for Refractory Congestive Heart Failure: Study Protocol for a Multicenter Randomized Clinical Trial
BACKGROUND: The high surgical risk in redo cardiac surgery is largely attributed to adhesions around the epicardium and the great vessels. BAX602 is an adhesion prevention reagent composed of two synthetic polyethylene glycols. Spraying BAX602 over the epicardium and the great vessels reportedly con...
Autores principales: | Fukushima, Satsuki, Asakura, Koko, Hamasaki, Toshimitsu, Onda, Kaori, Watanabe, Takuya, Shiose, Akira, Ono, Minoru, Fukushima, Norihide, Yamamoto, Haruko, Fujita, Tomoyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497303/ https://www.ncbi.nlm.nih.gov/pubmed/32444994 http://dx.doi.org/10.1007/s10557-020-06990-2 |
Ejemplares similares
-
Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial
por: Fukushima, Norihide, et al.
Publicado: (2018) -
Bridge from central extracorporeal life support is a risk factor of cerebrovascular accidents after durable left ventricular assist device implantation
por: Tonai, Kohei, et al.
Publicado: (2021) -
Can the intermittent low-speed function of left ventricular assist device prevent aortic insufficiency?
por: Kohno, Hiroki, et al.
Publicado: (2021) -
Efficacy of central extracorporeal life support for patients with fulminant myocarditis and cardiogenic shock
por: Tadokoro, Naoki, et al.
Publicado: (2021) -
Group-sequential clinical trials with multiple co-objectives
por: Hamasaki, Toshimitsu, et al.
Publicado: (2016)